(Q33378149)

26 July 2017

1 reference

title

Management of diarrhea-associated hemolytic uremic syndrome in children (English)

1 reference

26 July 2017

0 references

Kazumoto Iijima

1

1 reference

26 July 2017

Ichiro Kamioka

series ordinal

2

1 reference

26 July 2017

Kandai Nozu

series ordinal

3

1 reference

26 July 2017

publication date

5 January 2008

1 reference

Clinical and experimental nephrology

26 July 2017

published in

1 reference

26 July 2017

volume

12

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

16-19

1 reference

https://scigraph.springernature.com/pub.10.1007/s10157-007-0007-4

26 July 2017

exact match

0 references

cites work

Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10157-007-0007-4

CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10157-007-0007-4

Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands

21 January 2018

1 reference

12 December 2020

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

1 reference

12 December 2020

Plasma therapy for severe hemolytic-uremic syndrome in children in Atlantic Canada.

1 reference

12 December 2020

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

1 reference

12 December 2020

Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers

1 reference

12 December 2020

Steroids in the hemolytic uremic syndrome

1 reference

12 December 2020

The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients

1 reference

12 December 2020

Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections

1 reference

12 December 2020

Escherichia coli O157:H7

1 reference

12 December 2020

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

1 reference

12 December 2020

Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection

1 reference

12 December 2020

Risk factors for developing severe clinical course in HUS patients: a national survey in Japan

1 reference

12 December 2020

Haemolytic uraemic syndrome: 17 years' experience in a Scottish paediatric renal unit

1 reference

12 December 2020

Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.

1 reference

12 December 2020

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools

1 reference

12 December 2020

Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: experience of an outbreak in Sakai City, 1996

1 reference

12 December 2020

Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis

1 reference

12 December 2020

Treatment of the hemolytic-uremic syndrome with streptokinase and heparin (author's transl)

1 reference

12 December 2020

Escherichia coli O157:H7.

1 reference

12 December 2020

Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome

1 reference

12 December 2020

Verotoxin (shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: possible implications for the hemolytic uremic syndrome

1 reference

12 December 2020

Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

1 reference

12 December 2020

Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996

1 reference

12 December 2020

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

1 reference

12 December 2020

Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response

1 reference

12 December 2020

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion

1 reference

12 December 2020

Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

12 December 2020

10.1007/S10157-007-0007-4

Identifiers

DOI

1 reference

26 July 2017

1 reference